THE ADVI ANGLE

Resources and insights to help you keep up with policy and market trends in a transforming healthcare ecosystem

Showing In the Press

Our VP of Policy Lindsay Bealor Greenleaf weighed in on the possible unintended consequences of the int’l reference pricing Executive Order with CNBC

Our VP of Policy Lindsay Bealor Greenleaf weighed in on the possible unintended consequences of the int’l reference pricing
Executive Order with CNBC

Read more

Lindsay Bealor Greenleaf, VP of Policy at ADVI, recently shared her thoughts with Bloomberg Law about the impacts of an appeals court decision to uphold reimbursement cuts for hospitals receiving drugs under the 340B discount program

Lindsay Bealor Greenleaf, VP of Policy at ADVI, recently shared her thoughts with Bloomberg Law about the impacts of an appeals court decision to uphold reimbursement cuts for hospitals receiving drugs under the 340B discount program.

Read more

ADVI Director, Becca Davison, sat down with Modern Healthcare to discuss the lack of transparency surrounding 340B and how manufacturers are engaging with entities utilizing the program

ADVI Director, Becca Davison, sat down with Modern Healthcare to discuss the lack of transparency surrounding 340B and how manufacturers are engaging with entities utilizing the program.

Read more

ADVI’s Vice President, Dr. Michael Kolodziej, talked to The American Journal of Managed Care about the side effects of first-gen BTK inhibitors

“The thinking is that the reduced cardiovascular side effects, the reduced bleeding, are going to allow a better persistence on the second-generation drugs”

Read more